Caris Life Sciences, Inc. - CAI

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
May 12, 2026 SCHEDULE 13G/A TSSP Sub-Fund HoldCo, LLC 4.8% 13,666,128 View
May 12, 2026 SCHEDULE 13G/A Alan Waxman 5.1% 14,385,399 View
May 12, 2026 SCHEDULE 13G/A J H Whitney VI L P 6.5% 18,256,615 View
May 12, 2026 SCHEDULE 13G/A J. H. Whitney Equity Partners VI, LLC 6.5% 18,256,615 View
May 12, 2026 SCHEDULE 13G/A VIGANO PAUL R 6.5% 18,256,615 View
May 12, 2026 SCHEDULE 13G/A WILLIAMS ROBERT M JR 6.5% 18,256,615 View
Apr 07, 2026 SCHEDULE 13G/A FMR LLC 10.8% 30,631,585 View
Apr 07, 2026 SCHEDULE 13G/A Abigail P. Johnson 10.8% 30,631,585 View
Feb 13, 2026 SCHEDULE 13G/A TSSP Sub-Fund HoldCo, LLC 6.5% 18,416,128 View
Feb 13, 2026 SCHEDULE 13G/A Alan Waxman 6.9% 19,385,399 View
Feb 05, 2026 SCHEDULE 13G FMR LLC 5.0% 14,143,768 View
Feb 05, 2026 SCHEDULE 13G Abigail P. Johnson 5.0% 14,143,768 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.